| The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment E Coban, B Afacan Platelets 19 (2), 111-114, 2008 | 121 | 2008 |
| Gibberellic acid, a plant growth regulator, increases mast cell recruitment and alters Substance P levels N Erin, B Afacan, Y Ersoy, F Ercan, MK Balcı Toxicology 254 (1-2), 75-81, 2008 | 80 | 2008 |
| The role of CD200 and CD43 expression in differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma M Falay, BA Öztürk, K Güneş, Y Kalpakçı, S Dağdaş, F Ceran, G Özet Turkish journal of hematology 35 (2), 94, 2018 | 35 | 2018 |
| Dimethyl sulfoxide-induced tonic-clonic seizure and cardiac arrest during infusion of autologous peripheral blood stem cells S Maral, M Albayrak, C Pala, A Yildiz, O Sahin, HB Ozturk Cell and tissue banking 19, 831-832, 2018 | 32 | 2018 |
| The incidence and risk factors of thrombosis and the need for thromboprophylaxis in lymphoma and leukemia patients: a 9-year single-center experience A Yıldız, M Albayrak, Ç Pala, HB Afacan Öztürk, S Maral, O Şahin, ... Journal of Oncology Pharmacy Practice 26 (2), 386-396, 2020 | 14 | 2020 |
| The Turkish experience with therapeutic plasma exchange: A national survey S Korkmaz, SS Medeni, F Demirkan, SK Besisik, SA Dadin, GA Cagliyan, ... Transfusion and Apheresis Science 58 (3), 287-292, 2019 | 14 | 2019 |
| Biological variation estimates of prothrombin time, activated partial thromboplastin time, and fibrinogen in 28 healthy individuals M Falay, M Senes, S Korkmaz, T Turhan, M Okay, BA Öztürk, D Yücel, ... International Journal of Laboratory Hematology 40 (6), 721-725, 2018 | 14 | 2018 |
| The outcome of COVID-19 in patients with hematological malignancy P Tığlıoğlu, M Albayrak, M Tığlıoğlu, HBA Öztürk, MR Aras, B Sağlam, ... memo-Magazine of European Medical Oncology, 1-7, 2021 | 10 | 2021 |
| The impact of waist-to-hip ratio on clinical outcomes in metastatic breast cancer patients treated with aromatase inhibitors M Artac, H Bozcuk, B Afacan, M Ozdogan, M Samur The Breast 17 (4), 418-422, 2008 | 10 | 2008 |
| Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case HB Afacan Ozturk, M Albayrak, S Maral, M Reis Aras, F Yilmaz, P Akyol, ... Journal of Oncology Pharmacy Practice 27 (8), 2027-2029, 2021 | 9 | 2021 |
| Infections in patients with lymphoma: an analysis of incidence, relationship and risk factors A Yıldız, M Albayrak, Ç Pala, O Şahin, HBA Öztürk, G Güneş, S Maral, ... The Journal of Infection in Developing Countries 12 (09), 741-747, 2018 | 9 | 2018 |
| A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis UY Malkan, M Albayrak, A Yildiz, S Maral, HB Afacan Ozturk, P Comert Journal of Oncology Pharmacy Practice 27 (1), 250-252, 2021 | 8 | 2021 |
| Refractory thrombotic thrombocytopenic purpura in a patient with Kaposi sarcoma O Sahin, M Albayrak, A Yıldız, Ç Pala, L Aktas, S Maral, HBA Öztürk, ... Transfusion and Apheresis Science 58 (2), 187-189, 2019 | 8 | 2019 |
| Prognostic value of baseline serum lactate dehydrogenase level in patients with hairy cell leukemia S Maral, M Albayrak, S Dagdas, A Yıldız, R Yıldırım, M Oz, C Pala, ... Clinical Lymphoma Myeloma and Leukemia 20 (9), e616-e621, 2020 | 7 | 2020 |
| The Real‐World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL S Akpinar, MH Dogu, S Celik, O Ekinci, IY Hindilerden, MS Dal, ... Clinical Lymphoma Myeloma and Leukemia 22 (3), 169-173, 2022 | 6 | 2022 |
| Hereditary breast-ovarian cancer and BRCA1/BRCA2 variants: a single center experience A Gezdirici, EG İli, B Değirmenci, AA Gümüş, G Özdemir, NA Erman, ... Acta Oncologica Turcica 54 (3), 264-272, 2021 | 6 | 2021 |
| Neonatal osteofibrous dysplasia: a case report. B Sarisozen, C Ozturk, Z Yazici, H Ozturk European Journal of Orthopaedic Surgery & Traumatology 15 (1), 2005 | 6 | 2005 |
| Thrombocytopenia due to rivaroxaban: A rare adverse effect M Tığlıoğlu, P Akyol, B Sağlam, MR Aras, HBA Öztürk, A Yıldız, ... Transfusion and Apheresis Science 59 (6), 102883, 2020 | 5 | 2020 |
| CD81 expression in the differential diagnosis of chronic lymphocytic leukemia HB Afacan-Öztürk, M Falay, M Albayrak, A Yıldız, ҪP Öztürk, S Maral, ... Clin Lab 65 (3), 802-813, 2019 | 5 | 2019 |
| The prognostic impact of comorbidity, nutritional and performance status on patients with diffuse large B cell lymphoma B Saglam, M Albayrak, A Yıldız, P Akyol, M Tiglioglu, M Aras, F YıLmaz, ... Hematology, Transfusion and Cell Therapy 42, 21, 2020 | 4 | 2020 |
